BioPharma
01 November, 2024 | Friday | Interview
Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology
In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher Scientific, shares insights into the company’s la...
Lab
05 November, 2024 | Tuesday | News
Parse Biosciences Launches Evercode™ Low Input Fixation Kits, Enabling Single Cell Sequencing with Minimal Starting Material
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch and availability of Evercode™ Low Input Fixation kits for both cells...
BioTech
30 October, 2024 | Wednesday | News
Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
As JLABS Singapore marks its first anniversary, Alessandro Falcone, Head of JLABS Singapore, speaks with BioPharma APAC about the incubator’s rapid success in fostering biotech innovation. Established thr...
Contract Services
05 November, 2024 | Tuesday | News
Medidata Introduces Oncology and Vaccine Solutions to Streamline Phase II and III Trials with FDA-Aligned Patient-Centric Design
The new products combine Medidata's diverse technologies and experience from thousands of previous trials to streamline the management of Phase II and Phase III studies in specific therapeutic areas and r...
Consumer Health
01 November, 2024 | Friday | News
NCCN and Vietnam National Cancer Hospital Unite to Elevate Cancer Care Standards Across Vietnam
As part of ongoing work to define and advance high-quality cancer care globally, leaders from the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the U...
White Paper
01 November, 2024 | Friday | News
AllazoHealth’s AI Personalization Boosts Therapy Initiation by 10.4% for Rare Disease Patients
Product Spot Light
05 November, 2024 | Tuesday | News
Parse Biosciences Launches Evercode™ Low Input Fixation Kits, Enabling Single Cell Sequencing with Minimal Starting Material
Premium Article
20 September, 2024 | Friday | Opinion
The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
Bio Invest
06 November, 2024 | Wednesday | News
Vitrian Invests $50M in AmplifyBio’s Manufacturing Enablement Center, Driving Biomanufacturing Growth in Central Ohio
Biopharma APAC Infomercial
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
